Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Egfr Tyrosine Kinase Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01915524
What this trial is testing

Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Carcinoma
CureVac 26
Not applicableStudy completedNCT03421912
What this trial is testing

Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)

Who this might be right for
Head and Neck Squamous Cell CarcinomaColorectal CancerNon Small Cell Lung Cancer+1 more
Centre Leon Berard 102
Large-scale testing (Phase 3)Looking for participantsNCT06643416
What this trial is testing

Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia

Who this might be right for
ParonychiaEGFR-TKIALK-TKI
Queen Mary Hospital, Hong Kong 40
Testing effectiveness (Phase 2)Ended earlyNCT02495233
What this trial is testing

ASP2215 in Combination With Erlotinib in Subjects With Epidermal Growth Factor Receptor (EGFR) Activating Mutation-Positive (EGFRm+) Advanced Non-Small-Cell Lung Cancer (NSCLC) Who Have Acquired Resistance to an EGFR Tyrosine Kinase Inhibitor (TKI)

Who this might be right for
Non-Small-Cell Lung Cancer
Astellas Pharma Global Development, Inc. 10
Testing effectiveness (Phase 2)UnknownNCT04811001
What this trial is testing

Best EGFR-TKI Sequence in NSCLC Harboring EGFR Mutations

Who this might be right for
NSCLC
Fondazione Ricerca Traslazionale 170
Early research (Phase 1)Study completedNCT01999985
What this trial is testing

Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-small Cell Lung Cancer (NSCLC)
H. Lee Moffitt Cancer Center and Research Institute 25
Large-scale testing (Phase 3)UnknownNCT06140186
What this trial is testing

Efficacy and Safety of Timolol for TKI Induced Paronychia

Who this might be right for
Paronychia
Queen Mary Hospital, Hong Kong 40
Testing effectiveness (Phase 2)Study completedNCT06083662
What this trial is testing

Neratinib and Trastuzumab Biosimilar in Patients with HER2 Mutated Advanced Solid Cancers

Who this might be right for
Metastatic CancerHER2 Gene Mutation
Korea University Guro Hospital 42
Testing effectiveness (Phase 2)UnknownNCT00973310
What this trial is testing

Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Tianjin Medical University Cancer Institute and Hospital 50
Not applicableStudy completedNCT04179890
What this trial is testing

The Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mutations or for Common Mutations in the Sequence Afatinib Followed by Osimertinib

Who this might be right for
Non-squamous, Non-Small Cell Lung Cancer
Boehringer Ingelheim 462
Testing effectiveness (Phase 2)Ended earlyNCT00402896
What this trial is testing

Malignant Pleural Effusion With ZD6474

Who this might be right for
Lung CancerPleural Effusion
M.D. Anderson Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT05636267
What this trial is testing

Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients

Who this might be right for
NSCLC
Akeso 59
Testing effectiveness (Phase 2)UnknownNCT02738983
What this trial is testing

RT Plus EGFR-TKI for Wild-type NSCLC

Who this might be right for
Non-small Cell Lung CancerEpidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)
Hangzhou Cancer Hospital 22
Not applicableUnknownNCT01697163
What this trial is testing

De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

Who this might be right for
NSCLC
Severance Hospital 155
Testing effectiveness (Phase 2)Study completedNCT00922584
What this trial is testing

Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor

Who this might be right for
Non-Small Cell Lung Cancer
Chinese Society of Lung Cancer 65
Not applicableStudy completedNCT05165082
What this trial is testing

The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitors-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled Study

Who this might be right for
ParonychiaEpidermal Growth Factor Receptor Inhibitor
Taipei Medical University WanFang Hospital 8
Not applicableStudy completedNCT01393821
What this trial is testing

Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab

Who this might be right for
Dermatologic ComplicationsMalignant NeoplasmPain
Mayo Clinic 27
Testing effectiveness (Phase 2)Ended earlyNCT00063258
What this trial is testing

Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 5
Not applicableStudy completedNCT03309462
What this trial is testing

Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted Therapy

Who this might be right for
Lung Cancer
Shanghai Chest Hospital 50
Early research (Phase 1)Study completedNCT02574091
What this trial is testing

Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients

Who this might be right for
Psoriasis
Betta Pharmaceuticals Co., Ltd. 28
Next Page